# Filing Detail

Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-21-030754
Filing Date
2021-12-07
Accepted
2021-12-07 19:20:35
Documents
3
Period of Report
2021-12-07

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | ownership.html | 3 |
1 |  | ownership.xml | 3 | 2672
2 |  | ex24.htm | EX-24 | 1058
3 |  | ex24_001.jpg | GRAPHIC | 888617
| Complete submission text file | 0001493152-21-030754.txt |  | 1228724

Mailing Address 1901 W. 47TH PLACE KANSAS CITY KS 66205
Business Address 1901 W. 47TH PLACE KANSAS CITY KS 66205 (913) 942-2300
Cingulate Inc. (Issuer) CIK: 0001862150 (see all company filings)

EIN.: 863825535 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1764 LITCHFIELD TURNPIKE, SUITE 202 WOODBRIDGE CT 06525
Business Address 1764 LITCHFIELD TURNPIKE, SUITE 202 WOODBRIDGE CT 06525 203-387-7794
Werth Family Investment Associates LLC (Reporting) CIK: 0001885004 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40874 | Film No.: 211477292